LGND
Ligand Pharmaceuticals (LGND) Earnings
Review Ligand Pharmaceuticals (LGND) earnings with company data, supporting context and links to related investor research.
Research record updated: . Individual measures may refer to different reporting periods.
- Annual EPS
- 6.13
- Trailing EPS
- 9.35
- Annual revenue
- $268.09M
- Trailing revenue
- $290.54M
- Next earnings date
- 2026-08-06
Ligand Pharmaceuticals (LGND) Earnings research
The LGND earnings page organizes the available earnings-per-share and revenue context for Ligand Pharmaceuticals. Earnings trends are more informative when actual results are compared with prior periods, market expectations and management guidance.
Quarterly surprises can move a share price, but their long-term importance depends on margins, cash flow and the durability of demand. Continue to the financials and valuation pages for a broader view.